- Patent Title: Dendritic cell immune receptor activator, method for activating dendritic cell immune receptor, osteoclast formation inhibitor, method for inhibiting osteoclast formation, dendritic cell differentiation/proliferation inhibitor, method for inhibiting dendritic cell differentiation/proliferation, cytokine production inhibitor, method for inhibiting cytokine production, therapeutic method and screening method
-
Application No.: US15323748Application Date: 2015-07-10
-
Publication No.: US10792300B2Publication Date: 2020-10-06
- Inventor: Yoichiro Iwakura , Tomonori Kaifu , Rikio Yabe
- Applicant: TOKYO UNIVERSITY OF SCIENCE FOUNDATION
- Applicant Address: JP Tokyo
- Assignee: TOKYO UNIVERSITY OF SCIENCE FOUNDATION
- Current Assignee: TOKYO UNIVERSITY OF SCIENCE FOUNDATION
- Current Assignee Address: JP Tokyo
- Agency: Marshall, Gerstein & Borun LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4fc99123
- International Application: PCT/JP2015/069960 WO 20150710
- International Announcement: WO2016/006700 WO 20160114
- Main IPC: A61K31/715
- IPC: A61K31/715 ; C12N5/0784 ; G01N33/50
Abstract:
A dendritic cell immune receptor activator, comprising a compound having a sugar chain as an active ingredient, the sugar chain having a basic structure represented by the following formula: wherein, in the formula, a sialic acid does not exist at two non-reducing terminals, and each of x and y independently represents 3 or 4.
Public/Granted literature
Information query
